EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Targeting ferroptosis in cardio‐metabolic‐diseases: Mechanisms and therapeutic prospects

Jia-Bao Zhang, Jie Tong, Di-Yang Sun, Jiang-Tao Fu, Dong-Jie Li, Pei Wang iD

Medicinal Research Reviews · 2023-05 · 43 (3) · 683-712

DOI: 10.1002/med.21934 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Medicinal Research Reviews, online erschienen am 19.01.2023. Verfasst von Jia-Bao Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, College of Pharmacy, Naval Medical University/Second Military Medical University, Shanghai, China. Hauptthemen laut MEDLINE: Ferroptosis, Metabolic Diseases. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 159 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardio‐metabolic‐diseases (cardio‐metabolic‐diseases) are leading causes of death and disability worldwide and impose a tremendous burden on whole society as well as individuals. As a new type of regulated cell death (RCD), ferroptosis is distinct from several classical types of RCDs such as apoptosis and necroptosis in cell morphology, biochemistry, and genetics. The main molecular mechanisms of ferroptosis involve iron metabolism dysregulation, mitochondrial malfunction, impaired antioxidant capacity, accumulation of lipid‐related peroxides and membrane disruption. Within the past few years, mounting evidence has shown that ferroptosis contributes to the pathophysiological process in cardio‐metabolic‐diseases. However, the exact roles and underlying molecular mechanisms have not been fully elucidated. This review comprehensively summarizes the mechanism of ferroptosis in the development and progression of cardio‐metabolic‐diseases, so as to provide new insights for cardio‐metabolic‐diseases pathophysiology. Moreover, we highlight potential druggable molecules in ferroptosis signaling pathway, and discuss recent advances in management strategies by targeting ferroptosis for prevention and treatment of cardio‐metabolic‐diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisMetabolic DiseasesHumansApoptosisAntioxidantsLipid Peroxides

Stichwörter der Autor:innen

cardio-metabolic-diseasesferroptosislipid peroxidepotential druggable moleculestherapeutic target

Substanzen

AntioxidantsLipid Peroxides

Autor:innen und Institutionen

  • Department of Pharmacology, College of Pharmacy, Naval Medical University/Second Military Medical University, Shanghai, China.
  • Department of Pharmacy, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
  • Department of Pharmacy, General Hospital of the PLA Eastern Theater Command, Nanjing, China.
  • National Experimental Teaching Demonstration Center of Pharmacy, Naval Medical University/Second Military Medical University, Shanghai, China.

ORCID-Profile: Pei Wang

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zhang, J. B., Tong, J., Sun, D. Y., Fu, J. T., Li, D. J., & Wang, P. (2023). Targeting ferroptosis in cardio‐metabolic‐diseases: Mechanisms and therapeutic prospects. Medicinal Research Reviews, 43(3), 683-712. https://doi.org/10.1002/med.21934

Vancouver

Zhang JB, Tong J, Sun DY, Fu JT, Li DJ, Wang P. Targeting ferroptosis in cardio‐metabolic‐diseases: Mechanisms and therapeutic prospects. Medicinal Research Reviews. 2023;43(3):683-712. doi:10.1002/med.21934

BibTeX
@article{Zhang2023,
  author = {Zhang, Jia-Bao and Tong, Jie and Sun, Di-Yang and Fu, Jiang-Tao and Li, Dong-Jie and Wang, Pei},
  title = {Targeting ferroptosis in cardio‐metabolic‐diseases: Mechanisms and therapeutic prospects},
  journal = {Medicinal Research Reviews},
  year = {2023},
  volume = {43},
  number = {3},
  pages = {683--712},
  doi = {10.1002/med.21934}
}
Kostenlos starten →